Chronic Myeloproliferative Disorders, specifically, Essential Thrombocytosis, Polycythemia Vera, & Primary Myelofibrosis have a mutation in
a) JAK2 kinase
b) BCR-ABL fusion protein
c) FLT3 receptor
d) RET proto-oncogene